Item 5.07 Submission of Matters to a Vote of Security Holders.
OnApril 12, 2023 , the virtual Special Meeting of stockholders (the "Special Meeting") ofVallon Pharmaceuticals, Inc. ("Vallon") to consider the proposals set forth in Vallon's proxy statement/prospectus/information statement datedMarch 8, 2023 , which was supplemented by the prospectus supplements filed with theU.S. Securities and Exchange Commission (the "SEC") onMarch 31, 2023 andApril 7, 2023 (together, the "Prospectus"), including the proposal to approve the issuance of shares of Vallon common stock pursuant to the Agreement and Plan of Merger, dated as ofDecember 13, 2022 and amended onFebruary 17, 2023 , by and among Vallon,GRI Bio, Inc. , andVallon Merger Sub, Inc. , was convened and adjourned, without any business being conducted other than the adjournment, to provide Vallon's stockholders additional time to consider the proposals. The virtual Special Meeting will be reconvened at9:00 a.m. Eastern Standard Time onApril 20, 2023 , through live audio webcast of the meeting, as described in the proxy card or in the instructions that accompanied the proxy materials to Vallon's stockholders. There was no change to the record date ofMarch 6, 2023 . Item 8.01 Other Events. OnApril 12, 2023 , Vallon issued a press release announcing the adjournment of the Special Meeting. A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description 99.1 Press Release issued byVallon Pharmaceuticals, Inc. , datedApril 12, 2023 . ______
Important Additional Information
In connection with the proposed Merger between Vallon and GRI, Vallon previously filed the Prospectus with theSEC , which base Prospectus had been previously filed, along with certain other related documents, in preliminary form in a registration statement on Form S-4 (the "Registration Statement"), which Prospectus constituted both the proxy statement to be distributed to Vallon's stockholders in connection with Vallon's solicitation of proxies for the vote by Vallon's stockholders with respect to the Merger and other matters as may be described in the Registration Statement, as well as the prospectus relating to the offer and sale of the securities of Vallon to be issued in the Merger. This Form 8-K is not a substitute for the Registration Statement, the Prospectus, or any other documents that Vallon has filed or may file with theSEC or send to its stockholders in connection with the proposed transactions. BEFORE MAKING ANY VOTING DECISION, VALLON URGES INVESTORS AND STOCKHOLDERS TO READ THESE MATERIALS CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT VALLON, THE PROPOSED TRANSACTIONS, AND RELATED MATTERS. You may obtain free copies of the Registration Statement, Prospectus, and all other documents filed or that will be filed with theSEC regarding the proposed transaction at the website maintained by theSEC at www.sec.gov. Investors and stockholders are urged to read the Registration Statement, Prospectus, and the other relevant materials before making any voting or investment decision with respect to the proposed transactions.
Participants in the Solicitation
Vallon and GRI, and each of their respective directors and executive officers and certain of their other members of management, employees, and agents, may be deemed to be participants in the solicitation of proxies in connection with the proposed transactions. Information about Vallon's directors and executive officers is included in Vallon's filings with theSEC , including Vallon's Annual Report on Form 10-K for the year endedDecember 31, 2022 (filed with theSEC onFebruary 24, 2023 ) and the Prospectus. These documents can be obtained free of charge from the source indicated above.
No Offer or Solicitation
This Form 8-K will not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities in connection with the proposed Merger shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. --------------------------------------------------------------------------------
Forward-Looking Statements
This Form 8-K contains forward-looking statements that involve risks and uncertainties. The risks and uncertainties involved include uncertainties relating to the other risks detailed from time to time in Vallon's periodic reports and other filings with theSEC . You are cautioned not to place undue reliance on forward-looking statements, which are based on Vallon's current expectations and assumptions and speak only as of the date of this Form 8-K. Vallon does not intend to revise or update any forward-looking statement in this Form 8-K as a result of new information, future events or otherwise, except as required by law.
--------------------------------------------------------------------------------
© Edgar Online, source